Breast Cancer Hormone Receptor-positive

• CLINICAL_TRIALS research · 2026-04-03
  Clinical Trial Update: ORION-1: Study of AVZO-023 as a Single Agent and in Combination With AVZO-021, and/or Endocrine Therapy in Advanced Solid Tumors [Phase 1, Phase 2]

  Clinical trial update for ORION-1 studying AVZO-023 as a single agent and in combination with AVZO-021 and/or endocrine therapy in advanced …

• CLINICAL_TRIALS research · 2026-01-07
  Clinical Trial Update: ETHAN - ET for Male BC [Phase 2]

  A Phase 2 trial named ETHAN is evaluating an ET-based therapy for male breast cancer. The study is currently recruiting.

• CLINICAL_TRIALS research · 2025-08-13
  Clinical Trial Update: Exploration of Dalpiciclib Plus HDACi in HR+/HER2- Advanced Breast Cancer After Failure of CDK4/6 Inhibitor [Phase 2]

  A Phase 2 trial is exploring the combination of dalpiciclib with a histone deacetylase inhibitor for HR+/HER2- advanced breast cancer after …